# Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage

> **NCT04116086** · NA · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Prostate Biopsy Test

## Key facts

- **NCT ID:** NCT04116086
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-11
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04116086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04116086, "Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04116086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*